Documentos de Académico
Documentos de Profesional
Documentos de Cultura
27 Nº 3 2017
Originales
GALLEGO ÚBEDA M1, DELGADO TÉLLEZ DE CEPEDA L1, CAMPOS FERNÁNDEZ DE SEVILLA MA1, EGÜES LUGEA A1,
IGLESIAS PEINADO I2, TUTAU GÓMEZ F1
1 Hospital Universitario del Henares. Coslada. Madrid (España)
2 Universidad Complutense de Madrid (España)
Correspondencia:
Marta Gallego Úbeda
Hospital del Henares
(Servicio de Farmacia)
Avda. Marie Curie, s/n
28822 Coslada (Madrid)
Correo electrónico: mgallegoubeda@hotmail.com
264
Revista de la OFIL
Interoperability applied to pharmaceutical care Results: The number of PI is reduced
from P1 (229) to P2 (96). The pres-
in patients with renal failure criber acceptance degree is increased
SUMMARY systems) was applied to three periods: (47.6% P1 vs. 77.1% P2). Drug with
Background: The complexity of the P0: prior to implementing the tool; P1: the highest number of PI: levofloxa-
use of drugs in patients with kidney at the beginning of the implementa- cin.
disease requires developing metho- tion, P2: one year after implantation. Most relevant PI had been at cardio-
dologies for efficient care avoiding A descriptive analysis was made for vascular disease.
drug related problems (DRPs). gender, age, MDRD-4, patients can- Conclusion: SONAR increases the de-
Objectives: To describe the characte- didates for PI, patients with PI, num- tection efficiency of DRPs, shows a
ristics of PI (pharmaceutical interven- ber of PI, acceptance degree of PI, high degree of acceptance of the PI,
tions) and their evolution over the analysis distribution by drug and ana- generates learning effect and PI con-
studied period in patients with impai- tomic system. fidence in health professionals and PI,
red renal function treated with drugs Kruskal-Wallis test was applied to es- generates consensus and well docu-
drugs that require adjustment. tablish statistical significance .Statis- mented recommendations, it is flexi-
Methods: retrospective study where a tically significant differences with a ble and prevents the excess of alerts
software (SONAR) based on interope- probability of less than 5% (p<0.05) and can be easily implemented with
rability (the ability to work integrated was considerated. multiple rules and criteria.
Key Words: Renal insufficiency, pharmaceutical intervention, interoperability, drug related problems, pharmaceutical
validation, software.
Figura 1
Metodología SONAR
Base
de datos
Recomendaciones
farmacéuticas
Datos de laboratorio
Servolab® Recomendación
PRM
Tratamiento
farmacológico
266
Revista de la OFIL
Figura 2
Pantalla SONAR: información clínica y farmacológica
267
Vol. 27 Nº 3 2017
Tabla 1
Características demográficas
Periodo 0 Periodo 1 Periodo 2
Sexo (%)
Mujeres 63,64% 54,43% 64%
Hombres 36,36 45,57% 36%
p<0,05 (no existen diferencias significativas en edad y promedio MDRD-4 en los tres periodos).
c
Tabla 2
Datos descriptivos
Periodo 0 Periodo 1 Periodo 2
Figura 4 Figura 5
Intervenciones farmacéuticas: distribución por Grado de aceptación y número de intervenciones
diagnóstico y por periodo
Periodo 0
221
30 29,6%
25 24%
20
15 14,1%
11,3% 96
10 9,8% 77,1%
5,6% 5,6%
5 47,6%
0
ivo
icas
r
io
rio
os
ula
one
tor
stic
rina
est
lóg
asc
cci
pira
gnó
dig
ato
itou
P1 P2
iov
nfe
res
hem
dia
to
ard
gen
as i
ara
co-
ac
os
Otr
ara
Ap
to
Otr
s on
em
ara
Ap
Sist
gía
Ap
olo
Pat
icas
rio
io
ivo
s
tico
ula
one
tor
rina
est
lóg
nós
cci
pira
dig
ato
itou
iov
iag
nfe
conflicto de intereses.
res
hem
to
ard
os d
gen
as i
ara
to
co-
ac
Otr
Otr
ara
to
Ap
BIBLIOGRAFÍA
s on
em
ara
Ap
gía
Ap
olo
rio
s
r
io
one
tor
esti
stic
rina
lóg
asc
dig
gnó
ato
itou
iov
nfe
rato
hem
dia
ard
gen
as i
Apa
co-
ac
os
Otr
ara
to
s on
em
ara
Ap
gía
Ap
Farm. 2011,13(5):257-270.
olo
Par
271